July 2016

AB Science announces that FDA approves first compassionate use of masitinib in amyotrophic lateral sclerosis

Founded in 2001, AB Science is a pharmaceutical company specializing in the research, development and commercialization ... progressive forms of multiple sclerosis, and amyotrophic lateral sclerosis. The company is headquartered in Paris, France, and ...

Herantis Pharma receives orphan designation in USA for CDNF for treatment of ALS

The United States Food and Drug Administration FDA has granted orphan designation for Herantis Pharma Plc's ("Herantis") CDNF for treatment of amyotrophic lateral sclerosis (ALS ... CDNF is based on research at the Institute of Biotechnology at the ...

Science : announces the announces the publication of preclinical study results with masitinib in amyotrophic lateral sclerosis (ALS)

About AB Science Founded in 2001, AB Science is a pharmaceutical company specializing in the research, development and commercialization ... progressive forms of multiple sclerosis, and amyotrophic lateral sclerosis. The company is headquartered in Paris ...

Stem cell therapy for amyotrophic lateral sclerosis - good results of doctors from Olsztyn

Doctors from the University Hospital in Olsztyn, who for several years have been doing research on the use of stem cells in patients with amyotrophic lateral sclerosis, have found that in approx. 70 percent patients they were able to slow the progression ...

OHSU Pushes ALS Research Gains

Lou Gehrig in 1937 Credit Harris & Ewing/Wikimedia Lou Gehrig's Disease--amyotrophic lateral sclerosis, or ALS--slowly erodes the body's motor functions, leading to paralysis and death. Oregon Health & Science University performs extensive research into ...

New report shares details about the amyotrophic lateral sclerosis - pipeline review for 2016

The report reviews pipeline therapeutics for Amyotrophic Lateral Sclerosis by companies and universities/research institutes based on information derived from company and industry-specific sources - The report covers pipeline products based on various ...

Escalated Application of Mesenchymal Stem Cells in Amyotrophic Lateral Sclerosis Patients

Condition: Motor Neuron Disease
Intervention: Biological: Autologous Mesenchymal stem cells (MSCs)
Sponsors: Hospital e Maternidade Dr. Christóvão da Gama; IEP São Lucas - Instituto de Ensino e Pesquisa; Clinica Jordy Sinapse; TECHLIFE - Centro de Tecnologia Celular
Active, not recruiting - verified January 2017

July 2016

AB Science announces that FDA approves first compassionate use of masitinib in amyotrophic lateral sclerosis

Herantis Pharma receives orphan designation in USA for CDNF for treatment of ALS

Science : announces the announces the publication of preclinical study results with masitinib in amyotrophic lateral sclerosis (ALS)

Stem cell therapy for amyotrophic lateral sclerosis - good results of doctors from Olsztyn

OHSU Pushes ALS Research Gains

New report shares details about the amyotrophic lateral sclerosis - pipeline review for 2016

Escalated Application of Mesenchymal Stem Cells in Amyotrophic Lateral Sclerosis Patients

Pages

Keep in touch

Be a team player

Learn about ALS

Get help

You are here

July 2016

Pages

Keep in touch

Be a team player

Learn about ALS

Get help